GLP-1s and the CPG Industry, Spring 2025 - Big Chalk
GLP-1 medications (Ozempic, Mounjaro, Wegovy, etc.) have reached a household penetration level at which their impact on grocery volumes can no longer be ignored. Big Chalk data shows 11.2% of adult U.S. consumers currently use a GLP-1; an additional 8.3% are considering a treatment plan in the next 12 months. Much like the Trade-Off Consumer – […]| Big Chalk
